Natalia Lapteva

NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

Robin Parihar, Charlotte Helena Rivas, Mai Huynh et al. · Cancer Immunology Research · 2019 · 246 citations · Full text

Large-scale ex vivo expansion and characterization of natural killer cells for clinical applications

Natalia Lapteva, April Durett, Jiali Sun et al. · Cytotherapy · 2012 · 202 citations · Full text

Cell Therapy, Adaptive Immune System, Immunology +5

Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients

Susann Szmania, Natalia Lapteva, Tarun K. Garg et al. · Journal of Immunotherapy · 2014 · 179 citations · Full text

Cell Therapy, Immunology, Immunoediting +23

Phase 1 clinical trial of adoptive immunotherapy using “off-the-shelf” activated natural killer cells in patients with refractory and relapsed acute myeloid leukemia

Michael Boyiadzis, Mounzer Agha, Robert L. Redner et al. · Cytotherapy · 2017 · 170 citations

Hematological Malignancy, Cell Therapy, Medicine +11

CXCR4 knockdown by small interfering RNA abrogates breast tumor growth in vivo

Natalia Lapteva, Angang Yang, Denise E Sanders et al. · Cancer Gene Therapy · 2004 · 165 citations

Breast Oncology, Medicine, Tumor Growth +9